Status:
RECRUITING
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
End of Life
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
Detailed Description
PRIMARY OBJECTIVES: I. Greater intervention effects on health-related quality of life SECONDARY OBJECTIVES: I. Greater intervention effects on patient activation II. Greater satisfaction with care ...
Eligibility Criteria
Inclusion
- Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
- Patients must have the ability to understand and willingness to provide verbal consent.
- Participants must speak English, Spanish, Chinese, or Vietnamese.
Exclusion
- Inability to consent to the study
- Plans to change oncologist within 12 months
- Employed by the practice site
- Patients who anticipate moving from the area within 12 months
Key Trial Info
Start Date :
June 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2028
Estimated Enrollment :
2996 Patients enrolled
Trial Details
Trial ID
NCT05297734
Start Date
June 24 2022
End Date
February 28 2028
Last Update
March 19 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
University of South Alabama
Mobile, Alabama, United States, 36688
3
Beckman Research Institute of City of Hope
Duarte, California, United States, 91010
4
VA Medical Center, Fresno
Fresno, California, United States, 93703